ANDERA PARTNERS

Position in AGMB — Agomab Therapeutics NV

CIK 1757283 PARIS, I0

Position in AGMB

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$16,140,983

New position

Shares Held

1,538,702

first reported quarter

Ownership

3.12%

of shares outstanding

% of Portfolio

9.12%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ANDERA PARTNERS holds $121,676,488 across 5 Biotechnology names. AGMB ranks #3 (13.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EVMN	Evommune, Inc.	1,897,362	$43,620,352
2	MLYS	Mineralys Therapeutics, Inc.	1,591,917	$43,125,031
3	AGMB	Agomab Therapeutics NV This page	1,538,702	$16,140,983
4	IVA	Inventiva S.A.	1,818,181	$10,090,904
5	ABVX	Abivax S.A.	78,125	$8,699,218

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,140,983	1,538,702	—	Shares	Sole	2026-05-11
No filing history on record for this holder in this stock.